Abstract
A reduced bone mineral density (BMD) is frequently observed in hypogonadal males; however, very little is known on bone and mineral metabolism in Klinefelter's syndrome (KS). In this study 32 XXY KS patients and 24 healthy age-matched male controls were examined. Serum total and free testosterone (TT and FT) were significantly lower in patients than in controls (TT in KS, 15.1±7.8 nmol/l; controls, 30.4±9.1;p<0.001. FT in KS, 81.8±24.9 pmol/l; controls, 135.7±16.4;p<0.001). 17β-Estradiol was slightly higher in KS patients (KS, 49.0±27.1 pg/ml; controls, 39.3±16.4 pg/ml), but the difference was not significant. BMD, measured at the spine (L2–4) and at the proximal epiphysis of the left femur, was similar in patients and in the control group (spine: KS, 1.016±0.142; controls, 1.085±0.144 g/cm2;p=not significant. Femoral neck: KS, 0.926±0.149; controls, 0.926±0.122 g/cm2;p=not significant). Bone GLA protein (BGP) was significantly higher in the KS group (12.7±4.8 vs 8.9±5.2 ng/ml;p<0.02), while serum calcium, serum phosphate, calciotrophic hormones and the fasting urinary hydroxyproline/creatinine ratio (OHP/Creat) were similar in the two groups. A positive relationship between FT and both spine and femoral BMD was found in KS patients. Furthermore, OHP/Creat ratio was inversely related to BMD at the femur, and positively related to BGP in KS patients, but not in normal subjects. These findings suggest that (1) KS patients have normal bone mass, most probably because the hypogonadism is moderate; and (2) patients with lower bone mass appear to have higher bone turnover.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Riggs BL, Melton LJ III. Evidence for two distinct syndromes of involutional osteoporosis. Am J Med 1983;75:899–901.
Geusens P, Dequekuer J, Verstraeten A, Nijs J. Age-, sex-, and menopause-related changes of vertebral and peripheral bone: population study using dual and single photon absorptiometry and radiogrammetry. J Nucl Med 1986;27:1540–9.
Trevisan C, Ortolani S, Bianchi ML, et al. Age, time since menopause, and body parameters as determinants of female spinal bone mass: a mathematical model. Calcif Tissue Int 1991;49:1–5.
Nordin BEC, Need AG, Chatterton BE, Horowitz M, Morris HA. The relative contribution of age and years since menopause to postmenopausal bone loss. J Clin Endocrinol Metab 1990;70:83–8.
Nordin BEC, Need AG, Bridges A, Horowitz M. Relative contributions of years since menopause to vertebral density in postmenopausal women. J Clin Endocrinol Metab 1992;74:20–3.
Luisetto G, Zangari M, Tizian L, Nardi A, Ramazzina E, Adami S, Galuppo P. Influence of aging and menopause in determining vertebral and distal forearm bone loss in adult healthy women. Bone Miner 1993;22:9–25.
Finckelstein JS, Klibanski A, Neer RM, Greenspan SL, Rosenthai DI, Crowley WF. Osteoporosis in men with idiopathic hypogonadotropic hypogonadism. Ann Intern Med 1987;106:354–61.
Jackson JA, Riggs MW, Spiekerman AN. Testosterone deficiency as a risk factor for hip fractures in man: a case-control study. Am J Med Sci 1992;304:4–8.
Seeman E, Melton LJ, O'Fallon WM, Riggs BL. Risk factors for spinal osteoporosis. Am J Med 1983;75:977–83.
Baran DT, Bergfeld MA, Teitelbaum SL, Avioli LW. Effect of testosterone therapy on bone formation in an osteoporotic hypo-gonadal male. Calcif Tissue Res 1978;26:103–6.
Finckelstein JS, Klibanski A, Neer RM, Doppelt SH, Rosenthal DI, Segre GW, Crowley WF. Increases in bone density during treatment of men with idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab 1989;69:776–83.
Cantrill JA, Denis P, Large DM, Neuman M, Anderson DC. Which testosterone replacement therapy? Clin Endocrinol 1984;21:97–107.
Smith DAS, Walker MS. Changes in plasma steroids and bone density in Klinefelter's syndrome. Calcif Tissue Res 1977;22:225–8.
Foresta C, Ruzza G, Mioni R, Meneghello A, Baccichetti C. Testosterone and bone loss in Klinefelter syndrome. Horm Metab Res 1983;15:56–7.
Delmas P, Meunier PJ. L'ostéoporose au cours du syndrome de Klinefelter. Données histologiques osseuses quantitatives dans cinq cas: relation avec la carence hormonale. Nouv Presse Med 1981;10:687–90.
Jackson JA, Kleerkoper M, Parfitt AM, Rao DS, Villanueva AR, Frame B. Bone histomorphometry in hypogonadal and eugona-dal men with spinal osteoporosis. J Clin Endocrinol Metab 1987;65:53–8.
Horowitz M, Wishart JM, O'Loughlin PD, Morris HA, Need AG, Nordin BEC. Osteoporosis and Klinefelter syndrome. Clin Endocrinol 1992;36:113–8.
Kubler A, Schulz G, Cordes U, Beyer J, Krause U. The influence of testosterone substitution on bone mineral density in patients with Klinefelter's syndrome. Exp Clin Endocrinol 1992;100:129–32.
Wong FH, Pun KK, Wang C. Loss on bone mass in patients with Klinefelter's syndrome despite sufficient testosterone replacement. Osteoporosis Int 1993;3:3–7.
Meier DE, Orwoll ES, Jones DIM. Marked disparity between trebecular and cortical bone loss with age in healthy men: measurement by vertical computed tomography and radial photon absorptiometry. Ann Intern Med 1984;101:605–12.
Botteon S, Luisetto G, Bonanni G, Tizian L, Motta RG, Mastrogiacomo I. Bone densitometry in patients with different kinds of hypogonadism. J Endocrinol Invest 1994;17(Suppl 2):61.
Hsueh WA, Hsu TH, Federmann DD. Endocrine features of Klinefelter's syndrome. Medicine (Baltimore) 1978;57:447–61.
Wang C, Baker HWG, Burger HG, et al. Hormonal studies in Klinefelter's syndrome. Clin Endocrinol 1975;4:399–411.
Friedman J, Raisz LG. Thyrocalcitonin: inhibitor of bone resorption in tissue culture. Science 1965;150:1465–6.
Milhaud G, Benezech-Lefevre M, Mowkhtar MS. Deficient calcitonin response to calcium stimulation in postmenopausal osteoporosis. Lancet 1978;1:475–8.
Chesnut CH III, Baylink DT, Sisom K, Nelp WP, Roos BA. Basal plasma immunoreactive calcitonin in postmenopausal osteoporosis. Metabolism 1980;29:559–62.
Taggart H, Chesnuth CH III, Ivey JL, Baylink DJ, Sisom K, Huber MB, Ross BA. Deficient calcitonin response to calcium stimulation in postmenopausal osteoporosis. Lancet 1982;1:475–8.
Foresta C, Zanatta GP, Busnardo B, Scanelli G, Scandellari C. Testosterone and calcitonin plasma levels in hypogonadal osteo-porotic young men. J Enocrinol Invest 1985;8:377–9.
Johansen JS, Giwercman A, Hartwell D, Nielsen CT, Price PA, Christiansen C, Skakkabaek NE. Serum bone GLA-protein as a marker of bone growth in children and adolescents: correlation with age, height, serum insulin-like growth factor I, and serum testosterone. J Clin Endocrinol Metab 1988;67:273–8.
Cole DEC, Carpenter TO, Gundberg CM. Serum osteocalcin in children with metabolic bone disease. J Pediatr 1985;106:770–6.
Kruse K, Kracht U. Evaluation of serum osteocalcin as an index of altered bone metabolism. Eur J Pediatr 1986;145:27–33.
Sorensen K. Klinefelter's syndrome in childhood, adolescence and youth: a genetic, clinical, development, psychiatric and psychological study. Lancaster, UK: Parthenon, 1988.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Luisetto, G., Mastrogiacomo, I., Bonanni, G. et al. Bone mass and mineral metabolism in Klinefelter's syndrome. Osteoporosis Int 5, 455–461 (1995). https://doi.org/10.1007/BF01626608
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01626608